Results 231 to 240 of about 132,691 (312)

Association between fatty liver and risk of liver failure in patients with acute hepatitis B: a retrospective cohort study. [PDF]

open access: yesFront Cell Infect Microbiol
Wang XH   +8 more
europepmc   +1 more source

Probability of HBsAg loss after nucleo(s)tide analogue withdrawal depends on HBV genotype and viral antigen levels

open access: yesJournal of Hepatology, 2022
BACKGROUND & AIMS Nucleo(s)tide analogue (NUC) withdrawal may result in HBsAg clearance in a subset of patients, but predictors remain ill-defined. METHODS We studied predictors of HBsAg loss after NUC withdrawal in a global cohort of HBeAg negative ...
Milan J Sonneveld   +2 more
exaly   +2 more sources

Cytosolic delivery of HBsAg and enhanced cellular immunity by pH-responsive liposome

Journal of Controlled Release, 2020
It remains a major challenge to prime the cytotoxic T lymphocytes (CTLs) response for the treatment of Hepatitis B virus (HBV) infection. Inspired by an important natural biological behavior, membrane fusion, we constructed a pH-responsive nanocarrier ...
Hua Yue
exaly   +2 more sources

Mutation of the “a” Determinant of HBsAg with Discordant HBsAg Diagnostic Kits

Viral Immunology, 2004
Sera from 1003 in- and out-patients were investigated for hepatitis B surface antigen (HBsAg) mutation at Siriraj Hospital, Bangkok, Thailand. Individual samples were screened using two commercial HBsAg kits on automatic machine-based assays set up in parallel. The first kit was a sandwich ELISA kit that used monoclonal capture/monoclonal conjugate and
Suda, Louisirirotchanakul   +5 more
openaire   +2 more sources

Composition of HBsAg is predictive of HBsAg loss during treatment in patients with HBeAg-positive chronic hepatitis B.

Journal of Hepatology, 2020
BACKGROUND & AIMS During treatment of chronic hepatitis B virus (HBV) infections, loss or seroconversion (SC) of the HBV surface antigen (HBsAg) is considered a functional cure. HBsAg consists of the large (LHBs), middle (MHBs), and small surface protein
M. Pfefferkorn   +11 more
semanticscholar   +1 more source

HBsAg seroclearance further reduces hepatocellular carcinoma risk after complete viral suppression with nucleos(t)ide analogues.

Journal of Hepatology, 2019
BACKGROUND & AIMS In treated patients with chronic hepatitis B (CHB) who have achieved complete viral suppression, it is unclear if functional cure as indicated by hepatitis B surface antigen (HBsAg) seroclearance confers additional clinical benefit.
T. Yip   +6 more
semanticscholar   +1 more source

Effects of hepatitis B surface antigen (HBsAg) positivity of donors in HBsAg(+) renal transplant recipients: comparison of outcomes with HBsAg(+) and HBsAg(−) donors

Transplant Infectious Disease, 2016
AbstractAimThe aim of this study was to determine the effects of hepatitis B surface antigen (HBsAg) positivity of the donors on graft survival and liver complications in HBsAg(+) renal transplant recipients.Patients and methodA group of 55 patients who underwent renal transplantation (RTx) in our hospital between 2001 and 2012 were included in the ...
Yilmaz, V. T.   +6 more
openaire   +3 more sources

Polypeptide composition of HBsag

Archives of Virology, 1977
Purified HBsag has a complex structure comprising 8 polypeptides. Some of these polypeptides are immunogenic and induce both humoral and cell-mediated immunity in guinea pigs.
E, Mineva   +3 more
openaire   +2 more sources

Home - About - Disclaimer - Privacy